Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03109236
Recruitment Status : Recruiting
First Posted : April 12, 2017
Last Update Posted : April 12, 2017
Sponsor:
Collaborators:
Singapore General Hospital
Tan Tock Seng Hospital
Changi General Hospital
Information provided by (Responsible Party):
National University Hospital, Singapore

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2020
Estimated Study Completion Date : March 31, 2021